{"gene":"ZIC2","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1998,"finding":"Heterozygous loss-of-function mutations in ZIC2 cause holoprosencephaly (HPE); haploinsufficiency for ZIC2 is sufficient to cause brain malformations, establishing ZIC2 as a dosage-sensitive transcription factor required for forebrain development.","method":"Molecular analysis of chromosome 13q32 deletions and direct sequencing of ZIC2 in HPE patients","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple independent cohorts and laboratories, loss-of-function mechanism confirmed by patient mutations and mouse models","pmids":["9771712"],"is_preprint":false},{"year":2000,"finding":"Reduced Zic2 expression (knockdown) in mice causes neurulation delay resulting in HPE and spina bifida, and delays differentiation of the dorsal neural plate (roof plate and neural crest), demonstrating that Zic2 expression level is critical for the timing of neurulation.","method":"Hypomorphic Zic2 knockdown mouse model; in situ hybridization for roof plate marker Wnt3a","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct loss-of-function genetic model with defined cellular and molecular phenotype, replicated in multiple subsequent studies","pmids":["10677508"],"is_preprint":false},{"year":2000,"finding":"ZIC2 and Sp3 repress Sp1-induced transcriptional activation of the human D1A dopamine receptor gene in an AR1 activator region-dependent manner; ZIC2 was identified by yeast one-hybrid screening as a factor binding AR1.","method":"Yeast one-hybrid screening, gel shift assays (EMSA), cotransfection luciferase reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast one-hybrid plus EMSA plus functional reporter assay in the same study, single lab","pmids":["10984499"],"is_preprint":false},{"year":2000,"finding":"Zic1 and Zic2 bind to specific sequences in the apolipoprotein E gene promoter (regions -185/-174, -136/-125, -65/-54) and transactivate APOE gene expression.","method":"Yeast one-hybrid screening, EMSA, mutational analysis, cotransfection luciferase reporter assays, endogenous APOE protein measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (EMSA, reporter, endogenous protein), single lab","pmids":["11038359"],"is_preprint":false},{"year":2002,"finding":"Zic2 and Zic1 cooperatively control cerebellar development by regulating neuronal differentiation; compound Zic1+/-/Zic2+/kd mice show cerebellar folial abnormalities with reduced cell proliferation in the external germinal layer, reduced cyclin D1, and enhanced p27/p16 expression.","method":"Compound mutant mouse genetics, in situ hybridization for zonal markers, immunohistochemistry for cell cycle regulators","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in compound mutant mice with multiple molecular readouts","pmids":["11756505"],"is_preprint":false},{"year":2003,"finding":"Zic2 is expressed in retinal ganglion cells (RGCs) with an uncrossed ipsilateral trajectory; loss- and gain-of-function analyses demonstrate that Zic2 is necessary and sufficient for RGC axon repulsion by cues at the optic chiasm midline, specifying the uncrossed retinal projection.","method":"In situ hybridization, immunofluorescence, loss-of-function (Zic2 mutant mice), gain-of-function (in vivo electroporation), axon tracing","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional loss- and gain-of-function with direct axon tracing readout, replicated across subsequent studies","pmids":["13678579"],"is_preprint":false},{"year":2003,"finding":"Zic2 mutation causes a delay in neural crest production and a decrease in neural crest cell number, and is required for normal hindbrain patterning (rhombomeres 3 and 5); these defects are independent of mediolateral segmentation or dorsal neurectoderm proliferation.","method":"Loss-of-function Zic2 allele (null); in situ hybridization for neural crest and hindbrain markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with multiple molecular and cellular readouts, epistasis established","pmids":["14651926"],"is_preprint":false},{"year":2004,"finding":"The C-terminal region of ZIC2 contains both activation and repression domains; the C-terminal alanine tract modulates DNA binding strength and transcriptional activity in a promoter-specific manner, and expansion of the alanine tract associated with HPE alters ZIC2 function.","method":"In vitro transcriptional activity assays, DNA binding assays with alanine-tract length mutants, analysis of HPE-associated mutations","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay with mutagenesis, single lab","pmids":["15590697"],"is_preprint":false},{"year":2007,"finding":"ZIC2-dependent transcriptional regulation involves two high-molecular-weight nuclear complexes: Complex I contains DNA-PKcs, Ku70/80, and PARP; Complex II contains Ku70/80 and RNA helicase A (RHA). DNA-PK phosphorylates Zic2, driving stepwise exchange from Complex I to Complex II; phosphorylated Zic2 forms a stable complex with RHA which can interact with RNA Pol II.","method":"Co-immunoprecipitation, subnuclear fractionation, in vitro phosphorylation assay, protein complex characterization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation reconstitution plus co-IP plus subnuclear localization, multiple orthogonal methods in one study","pmids":["17251188"],"is_preprint":false},{"year":2007,"finding":"Serine 200 of Zic2 is a phosphorylation site targeted by DNA-PK; S200A mutation abolishes RNA helicase A (RHA) binding and diminishes transcriptional activation capacity, establishing phosphorylation-dependent regulation of Zic2 transcriptional activity.","method":"Site-directed mutagenesis, co-immunoprecipitation, transcriptional reporter assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis plus functional assay plus binding assay, single lab but multiple methods","pmids":["18068128"],"is_preprint":false},{"year":2008,"finding":"Zic2 is required and sufficient to change RGC axon trajectories from crossed to uncrossed; Zic2 regulates EphB1 expression in RGCs (an EphB1-dependent pathway), and also controls axon divergence via an EphB1-independent pathway.","method":"In vivo gain- and loss-of-function in mouse (electroporation, Zic2 mutants), EphB1 protein expression analysis, axon tracing","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetics plus molecular target identification replicated by two independent studies","pmids":["18417618"],"is_preprint":false},{"year":2008,"finding":"Ectopic delivery of Zic2 into non-ventrotemporal retinal explants induces EphB1 mRNA and protein expression in growth cones, and the upregulated EphB1 is functional, switching RGC axon behavior from extension onto to avoidance of ephrinB2 substrates, establishing a direct link between Zic2 transcription factor activity and EphB1-mediated guidance receptor expression.","method":"Retinal explant electroporation, immunofluorescence for EphB1 protein in growth cones, ephrinB2 substrate avoidance assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function in explants with direct protein detection and functional axon guidance assay","pmids":["18524895"],"is_preprint":false},{"year":2008,"finding":"Zic2-associated HPE is caused by a transient defect in organizer region function at mid-gastrulation, causing arrest in prechordal plate (PCP) development; this defect precedes the onset of Shh signaling and Zic2 does not interact with Shh to produce HPE.","method":"Mouse genetics (Zic2 mutants), molecular marker analysis of prechordal plate, genetic epistasis with Shh pathway mutants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple molecular markers and negative interaction with Shh pathway established","pmids":["18617531"],"is_preprint":false},{"year":2010,"finding":"Zic2 controls eye-specific axonal refinement at visual targets by directly regulating expression of the serotonin transporter (Sert); RGCs ectopically expressing Zic2 show defects in axonal refinement and respond to pharmacological blockade of Sert, whereas Zic2-negative contralateral RGCs do not.","method":"Gain-of-function electroporation, pharmacological Sert blockade, axon refinement assays, ChIP/promoter analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct gain-of-function with molecular target identification and pharmacological rescue","pmids":["20676059"],"is_preprint":false},{"year":2011,"finding":"ZIC2 binds directly to the DNA-binding HMG box of TCF4 via its zinc finger domain and inhibits β-catenin·TCF4-mediated transcription without affecting TCF4 DNA binding; Zic2 RNA injection blocks β-catenin-induced axis duplication in Xenopus and inhibits Wnt target gene expression.","method":"Co-immunoprecipitation, luciferase reporter assays, Xenopus axis duplication assay, morpholino knockdown in transgenic Wnt reporter Xenopus","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein-protein interaction (Co-IP with domain mapping), functional reporter assay, and in vivo Xenopus validation","pmids":["21908606"],"is_preprint":false},{"year":2011,"finding":"Zic2 physically interacts with Gli1 and retains Gli1 in the nucleus, increasing Gli-mediated transcriptional activity; deletion of the C-terminal zinc finger domain of Zic2 abrogates Gli1 interaction and nuclear retention, as well as oncogenic properties in cervical cancer cells.","method":"Co-immunoprecipitation, subcellular fractionation, immunofluorescence, luciferase reporter assay, gain- and loss-of-function","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus fractionation plus functional reporter, single lab","pmids":["21661123"],"is_preprint":false},{"year":2011,"finding":"Zic2 and Zic1 act as coactivators of Gli-dependent Myf5 epaxial somite-specific enhancer activity; Zic2 co-immunoprecipitates with Gli2, indicating formation of Zic2-Gli2 complexes that promote Myf5 expression. Myf5 expression in newly forming somites is delayed in Zic2 mutant embryos.","method":"Co-immunoprecipitation, reporter assays in cell lines, presomitic mesoderm explants, in situ hybridization in Zic2 mutant embryos","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional reporter plus in vivo genetic evidence, single lab","pmids":["21211521"],"is_preprint":false},{"year":2013,"finding":"Zic2 determines axonal ipsilaterality in ascending dorsospinal tracts and rostromedial thalamocortical projections by inducing EphA4 expression to prevent midline crossing, and by downregulating Robo3 to ensure axons enter dorsal tracts.","method":"In vivo gain- and loss-of-function (electroporation, conditional KO), axon tracing, immunofluorescence, gene expression analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetics with identification of two downstream molecular targets and direct axon tracing readout","pmids":["24360543"],"is_preprint":false},{"year":2014,"finding":"Zic2 controls formation and function of node cilia during gastrulation to establish cardiac situs; Zic2 mutant embryos have dysmorphic, short node cilia and depleted expression of ciliogenesis regulators Noto, Rfx3, Foxj1, and Pkd1l1 at the mid-gastrula node.","method":"Mouse genetics (Zic2 mutants), electron microscopy of node cilia, in situ hybridization for ciliogenesis transcription factors","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with direct morphological analysis plus molecular marker changes, single lab","pmids":["24585447"],"is_preprint":false},{"year":2015,"finding":"Zic2 preferentially binds transcriptional enhancers genome-wide in embryonic stem cells and functions with the Mbd3/NuRD complex to regulate chromatin state and transcriptional output of differentiation-linked genes; Zic2 is required for proper ESC differentiation.","method":"ChIP-seq, genome-wide molecular studies, biochemical interaction with Mbd3/NuRD, loss-of-function in ESCs","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq plus biochemical co-purification plus functional differentiation assay in a single rigorous study","pmids":["25699711"],"is_preprint":false},{"year":2015,"finding":"ZIC2 acts upstream of OCT4 in liver cancer stem cells; ZIC2 recruits the NURF chromatin remodeling complex to the OCT4 promoter to initiate OCT4 transcriptional activation, thereby maintaining CSC self-renewal.","method":"ChIP assay, promoter reporter assay, co-immunoprecipitation, knockdown/overexpression with sphere formation and xenograft readouts","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus Co-IP plus functional readout, single lab","pmids":["26426078"],"is_preprint":false},{"year":2015,"finding":"Zic2 controls migration of three distinct forebrain neuron populations (Cajal-Retzius cells, an amygdaloid cell group from the caudal pallium, and cells from the prethalamic neuroepithelium to the ventral lateral geniculate nucleus); EphB1, a Zic2 transcriptional target, mediates at least part of Zic2-dependent migratory events.","method":"Zic2 conditional and hypomorphic mutant mice, in vivo cell tracking, in utero electroporation, immunofluorescence","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with direct cell tracking plus target identification, single lab","pmids":["26269635"],"is_preprint":false},{"year":2016,"finding":"ZIC2 physically interacts with SMAD2 and SMAD3 (the receptor-activated NODAL signal transducers) and together SMAD3 and ZIC2 regulate FOXA2 transcription; ZIC2 therefore acts downstream of the NODAL signal during prechordal plate development, and HPE-associated ZIC2 variants are deficient in SMAD-dependent transcription.","method":"Co-immunoprecipitation (ZIC2-SMAD2/3), luciferase reporter assays (FOXA2 promoter), Xenopus developmental assays, mutagenesis of HPE-associated ZIC2 variants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus mutagenesis plus functional reporter plus in vivo Xenopus validation, multiple orthogonal methods","pmids":["27466203"],"is_preprint":false},{"year":2017,"finding":"Zic2 directly binds the PAK4 promoter and transcriptionally activates PAK4 expression; PAK4 then modulates cell growth via the Raf/MEK/ERK pathway downstream of Zic2 in hepatocellular carcinoma.","method":"ChIP assay, luciferase reporter assay, knockdown/rescue experiments, pathway inhibition","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter plus functional rescue, single lab","pmids":["28577975"],"is_preprint":false},{"year":2017,"finding":"ZIC2 is a substrate of the KSHV K-Rta E3 ubiquitin ligase; K-Rta directly interacts with ZIC2 and ubiquitinates it. ZIC2 localizes to immediate early and early gene cluster regions of the KSHV genome, tethers polycomb repressive complex 2 (PRC2) through physical interaction, and maintains H3K27me3 marks at the K-Rta promoter to sustain viral latency.","method":"Co-immunoprecipitation, ubiquitination assay, ChIP-seq, PRC2 interaction assay, ZIC2 depletion experiments","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus ChIP-seq, single lab studying an endogenous ZIC2 function","pmids":["28835494"],"is_preprint":false},{"year":2017,"finding":"ZIC2 in ChIP-seq of epiblast stem cells (EpiSCs) preferentially binds enhancers that regulate transcription factor genes; ZIC2 binding at enhancers in ESCs primes these regions for later OTX2/ZIC2-dependent activation in EpiSCs, representing a shift from SOX2/POU5F1 in ESCs to ZIC2/OTX2 as major acting TFs in EpiSCs.","method":"ChIP-seq with in vivo biotinylated ZIC2, OTX2, SOX2, POU5F1, POU3F1 in EpiSCs","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with multiple TFs providing mechanistic regulatory network insights, rigorous methodology","pmids":["28455373"],"is_preprint":false},{"year":2018,"finding":"ZIC2 directly binds a low-affinity binding site in the Nodal enhancer HBE (normally active in node precursor cells) and is required for Nodal expression at the node; loss of Zic2 prevents activation of the NODAL-dependent left-determining cascade in the lateral plate mesoderm.","method":"ChIP-seq data analysis, in vitro transcriptional assays, mutagenesis of ZIC2 binding sites, mouse Zic2 mutant gene expression analysis, 3D organ imaging","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus in vitro transcriptional assay plus mutagenesis plus in vivo validation, single lab","pmids":["29992973"],"is_preprint":false},{"year":2018,"finding":"ZIC2 directly regulates Tgif1 (another HPE-causative gene) expression; Zic2-binding sites (ZBS) on the 5' flanking region of Tgif1 were identified by ChIP and in vitro DNA binding assays, and are essential for Zic2-dependent transcriptional activation. Zic2 shows higher affinity to ZBS than GLI-binding sequences.","method":"Chromatin immunoprecipitation (ChIP), in vitro DNA binding assay, luciferase reporter assay with ZBS mutations","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vitro binding assay plus reporter mutagenesis, single lab, multiple methods","pmids":["29391420"],"is_preprint":false},{"year":2018,"finding":"A Zic2 missense mutation (R409P) in the zinc finger domain found in schizophrenia patients shows lowered transcription-activating capacity, impaired target DNA-binding, and impaired co-factor-binding, linking zinc finger domain integrity to Zic2 transcriptional function.","method":"Luciferase reporter assay, DNA binding assay, co-factor binding assay with mutant Zic2 protein","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay with mutagenesis and multiple functional readouts, single lab","pmids":["22355535"],"is_preprint":false},{"year":2019,"finding":"Zfp281 stabilizes Zic2 at enhancers and promoters in epiblast stem cells; Ehmt1 (H3K9 methyltransferase) and Zic2 act downstream of Zfp281 to drive exit from the ESC naive state and restrict reprogramming of EpiSCs to naive state.","method":"Comparative CRISPR screening in ESCs and EpiSCs, gain- and loss-of-function genetics, chromatin binding analysis","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen plus genetic epistasis plus chromatin binding, single lab","pmids":["31782544"],"is_preprint":false},{"year":2020,"finding":"Zic2 switches the Wnt5a-triggered alternative (non-canonical) Wnt pathway in ipsilateral retinal neurons by regulating expression of Wnt receptors and intracellular proteins; in combination with EphB1 receptor activation at the midline, βcatenin is phosphorylated to elicit axon repulsion.","method":"In vivo gain- and loss-of-function (electroporation, Zic2 conditional KO), transcriptomic analysis of Wnt receptor expression, axon tracing","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional genetics plus molecular target identification, single lab","pmids":["33188033"],"is_preprint":false},{"year":2020,"finding":"ZIC2 directly binds the STAT3 promoter and represses STAT3 transcription; ZIC2 knockdown induces STAT3 expression and increases phosphorylated STAT3 levels, and ZIC2's tumor suppressive function in breast cancer is mediated through STAT3 regulation.","method":"ChIP-seq, RNA-seq, luciferase reporter assay, siRNA knockdown/STAT3 inhibitor rescue","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus reporter assay plus functional rescue, single lab","pmids":["32064600"],"is_preprint":false},{"year":2020,"finding":"ZIC2 is identified as an essential gene for cardiac progenitor formation by genome-wide CRISPR screen; ZIC2 mutant hPSCs retain pluripotency markers but fail to differentiate into cardiomyocytes, instead switching to non-cardiac lineages, with disruption of apelin receptor-related signaling during mesoderm formation.","method":"Genome-wide CRISPR-knockout screen in hPSCs, stage-specific marker analysis (MESP1, ISL1), RNA-seq, single-cell RNA-seq","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — unbiased CRISPR screen with validation, single-cell transcriptomic mechanistic follow-up, single lab","pmids":["32129551"],"is_preprint":false},{"year":2020,"finding":"SOX2 and ZIC2 combinatorially activate the Sox2 D1 enhancer in embryonic neural tube and neural crest; both TFs bind the D1 enhancer sequence (confirmed by ChIP), and their co-expression activates the enhancer in both neural tube and neural crest contexts.","method":"Chicken embryo electroporation, TF binding site mutagenesis, ChIP analysis","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional mutagenesis plus in vivo electroporation, single lab","pmids":["31997540"],"is_preprint":false},{"year":2021,"finding":"ZIC2 directly binds the Axin2 promoter to transcriptionally repress Axin2 expression, leading to accumulation and nuclear translocation of β-catenin; ZIC2 also physically interacts with β-catenin, providing multilevel enhancement of Wnt/β-catenin signaling in colon cancer.","method":"ChIP assay, luciferase reporter assay, co-immunoprecipitation, loss-of-function with β-catenin protein level and nuclear translocation analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus Co-IP plus reporter plus functional rescue, single lab","pmids":["34099631"],"is_preprint":false},{"year":2021,"finding":"ZIC2 transcriptionally activates Src expression; silencing ZIC2 inactivates Src/FAK signaling and reduces anoikis resistance of NSCLC cells, placing ZIC2 upstream of Src/FAK pathway in lung cancer.","method":"ChIP assay, luciferase reporter assay, siRNA knockdown, in vitro anoikis assay, in vivo xenograft","journal":"Molecular therapy oncolytics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter plus functional phenotypic readout, single lab","pmids":["34514099"],"is_preprint":false},{"year":2021,"finding":"ZIC2 directly binds the SNHG12 lncRNA promoter and activates SNHG12 transcription; ZIC2-driven SNHG12 upregulation activates Notch signaling to promote endometrial cancer cell proliferation and migration.","method":"ChIP assay, dual luciferase reporter assay, knockdown/overexpression with functional cell assays","journal":"Molecular medicine reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — ChIP and reporter plus phenotypic readout, but mechanistic pathway connection is indirect and single lab","pmids":["34278490"],"is_preprint":false},{"year":2023,"finding":"ZIC2 positively regulates RUNX2 transcription in clear cell renal cell carcinoma; increased ZIC2 drives upregulation of Runx2 and downstream oncogenic functions including downregulation of NOLC1 and activation of AKT/mTOR signaling. ZIC2 expression is regulated by promoter hypomethylation and H3K4me3, and by positive transcriptional regulation from FOXM1.","method":"RNA-seq, ATAC-seq, ChIP-PCR, MS-PCR (methylation), luciferase reporter, loss-of-function/gain-of-function","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-PCR, ATAC-seq, and methylation analysis plus luciferase reporter, multiple methods, single lab","pmids":["37496990"],"is_preprint":false},{"year":2023,"finding":"ZIC2 activates JUNB promoter activity (confirmed by ChIP-seq and ChIP-qPCR) and drives MCSF secretion from NPC cells via JUNB, inducing M2 polarization of tumor-associated macrophages; blockade of JUNB or MCSF reverses ZIC2-mediated macrophage polarization.","method":"ChIP-seq, ChIP-qPCR, luciferase assay, RNA-seq, knockdown/overexpression with macrophage polarization assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus luciferase plus functional rescue in multiple assays, single lab","pmids":["37479694"],"is_preprint":false},{"year":2023,"finding":"BMP signaling is overactivated in Zic2 (Kumba) mutant mouse embryos, causing failed dorsolateral hinge point formation and spina bifida; RhoA/actomyosin signaling is also overactivated, causing F-actin accumulation. BMP inhibitor (dorsomorphin) rescues DLHP formation, and myosin inhibitor (Blebbistatin) normalizes actomyosin accumulation, revealing a dual-pathway mechanism.","method":"Mouse mutant embryo culture with pharmacological inhibitors (dorsomorphin, Blebbistatin), immunofluorescence for actomyosin, neural tube morphology analysis","journal":"Disease models & mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological rescue in genetic model with two orthogonal inhibitors revealing dual pathway, single lab","pmids":["36916392"],"is_preprint":false},{"year":2024,"finding":"ARID1A-BAF chromatin remodeler regulates ZIC2 genomic occupancy at EMT enhancers during cranial neural crest specification; in ARID1A-haploinsufficient cells, ZIC2 is excluded from EMT enhancers and relocates to neuronal enhancers. ZIC2 binding at EMT enhancers is ARID1A-dependent. In vivo, deletion of Zic2 impairs NCC delamination, while ZIC2 overexpression in chick embryos elicits ectopic neural crest delamination.","method":"CSS patient iPSC-derived CNCC differentiation, ChIP-seq (ARID1A, ZIC2), ATACseq, gain-of-function in chick (electroporation), Zic2 mouse KO NCC delamination analysis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq with patient iPSCs plus bidirectional in vivo genetics in two species (mouse and chick) plus mechanistic epistasis, rigorous multi-method study","pmids":["39226899"],"is_preprint":false},{"year":2024,"finding":"ZIC2 and ZIC3 recruit SWI/SNF to primed-specific enhancers to activate them during human primed pluripotency; loss of ZIC2/ZIC3 prevents enhancer activation similarly to SWI/SNF degradation, and also results in perturbed Polycomb activity and aberrant differentiation toward mesendoderm.","method":"Multi-omic analysis (ATAC-seq, ChIP-seq, RNA-seq) in hESC models across peri-implantation spectrum, loss-of-function of ZIC2/ZIC3, SWI/SNF degradation experiments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multi-omic genome-wide approach with genetic epistasis (ZIC2/3 KO vs SWI/SNF degradation), multiple orthogonal methods","pmids":["39358345"],"is_preprint":false}],"current_model":"ZIC2 is a zinc finger transcription factor that binds enhancers and promoters to activate or repress target genes (including EphB1, EphA4, Sert, OCT4, TGIF1, Nodal, FOXA2, PAK4, STAT3, Axin2, Src, JUNB) and functions through phosphorylation-regulated protein complexes (including DNA-PK/PARP/RNA helicase A), physical interactions with SMAD2/3 (NODAL pathway), TCF4 (Wnt pathway), Gli1/Gli2 (Hedgehog pathway), and Mbd3/NuRD and SWI/SNF chromatin remodelers at enhancers; it is dosage-sensitive and required for forebrain midline patterning (via prechordal plate establishment downstream of NODAL signaling), binocular visual circuit formation (by specifying ipsilateral RGC identity through EphB1/EphA4 induction), neural crest specification and EMT, node ciliogenesis and left-right axis determination, neurulation timing, cerebellar development, and stem cell state transitions."},"narrative":{"mechanistic_narrative":"ZIC2 is a dosage-sensitive zinc finger transcription factor that patterns the embryonic forebrain midline, neural tube, and binocular visual system, and regulates stem cell state transitions through enhancer-directed control of gene expression [PMID:9771712, PMID:13678579, PMID:25699711]. Heterozygous loss-of-function mutations cause holoprosencephaly, and reduced Zic2 dosage delays neurulation and dorsal neural plate differentiation, producing spina bifida [PMID:9771712, PMID:10677508]. ZIC2's forebrain function operates downstream of NODAL signaling: it physically interacts with the receptor-activated transducers SMAD2 and SMAD3 to control FOXA2 transcription during prechordal plate development, and HPE-associated variants are deficient in SMAD-dependent transcription [PMID:27466203, PMID:18617531]. The zinc finger domain mediates both DNA binding and protein-protein interactions, and its integrity is essential for transcriptional activity [PMID:15590697, PMID:22355535]. In the visual system, ZIC2 is necessary and sufficient to specify ipsilateral retinal ganglion cell identity by directly inducing EphB1 to drive midline axon repulsion, and it further shapes circuit assembly by inducing EphA4, downregulating Robo3, controlling the serotonin transporter Sert, and rewiring non-canonical Wnt5a signaling [PMID:13678579, PMID:18417618, PMID:18524895, PMID:24360543, PMID:20676059, PMID:33188033]. ZIC2 intersects multiple morphogen pathways as a context-dependent activator or repressor: it binds the HMG box of TCF4 to inhibit β-catenin·TCF4 transcription, interacts with Gli1/Gli2 to modulate Hedgehog output, and binds a low-affinity Nodal enhancer to drive node Nodal expression for left-right axis determination [PMID:21908606, PMID:21661123, PMID:21211521, PMID:29992973]. Genome-wide, ZIC2 preferentially occupies enhancers and works with chromatin machinery—the Mbd3/NuRD complex, NURF, and SWI/SNF—to set chromatin state and prime or activate cell-state-specific enhancers governing pluripotency exit and differentiation [PMID:25699711, PMID:26426078, PMID:39358345, PMID:28455373]. Its enhancer occupancy is directed by partner factors, including stabilization by Zfp281 and ARID1A-BAF-dependent targeting to EMT enhancers during cranial neural crest specification [PMID:31782544, PMID:39226899]. In cancer contexts ZIC2 acts as an enhancer/promoter-binding regulator of diverse targets including OCT4, PAK4, STAT3, Axin2, Src, and RUNX2 [PMID:26426078, PMID:28577975, PMID:32064600, PMID:34099631, PMID:34514099, PMID:37496990].","teleology":[{"year":1998,"claim":"Established ZIC2 as a dosage-sensitive transcription factor required for forebrain development by linking haploinsufficiency to a human malformation syndrome.","evidence":"Deletion mapping and direct ZIC2 sequencing in holoprosencephaly patients","pmids":["9771712"],"confidence":"High","gaps":["Did not define direct transcriptional targets","Mechanism of dosage sensitivity not resolved"]},{"year":2000,"claim":"Showed that Zic2 expression level controls the timing of neurulation, explaining how reduced dosage produces both HPE and spina bifida.","evidence":"Hypomorphic Zic2 knockdown mouse with roof plate marker analysis","pmids":["10677508"],"confidence":"High","gaps":["Molecular pathway linking Zic2 to neurulation timing not identified","Direct targets in the neural plate unknown"]},{"year":2000,"claim":"First identified ZIC2 as a sequence-specific DNA-binding transcription factor capable of both repression and activation at defined promoters.","evidence":"Yeast one-hybrid, EMSA, and reporter assays on D1A dopamine receptor and APOE promoters","pmids":["10984499","11038359"],"confidence":"Medium","gaps":["In vitro promoter assays without developmental context","Endogenous relevance of these targets not established"]},{"year":2002,"claim":"Demonstrated cooperative, dosage-dependent control of cerebellar neuronal differentiation by Zic genes through cell-cycle regulators.","evidence":"Compound Zic1/Zic2 mutant mouse genetics with cell-cycle marker analysis","pmids":["11756505"],"confidence":"High","gaps":["Direct vs indirect regulation of cyclin D1/p27/p16 not distinguished"]},{"year":2003,"claim":"Defined Zic2 as the determinant of ipsilateral retinal ganglion cell identity, providing a mechanism for binocular circuit formation.","evidence":"Bidirectional loss- and gain-of-function in mouse with axon tracing","pmids":["13678579","14651926"],"confidence":"High","gaps":["Downstream guidance effectors not yet identified at this stage"]},{"year":2004,"claim":"Mapped activation/repression domains and showed the C-terminal alanine tract modulates DNA binding and links HPE mutations to altered ZIC2 function.","evidence":"In vitro transcription and DNA-binding assays with alanine-tract mutants","pmids":["15590697"],"confidence":"Medium","gaps":["Promoter-specific effects not tested in vivo","Structural basis of alanine-tract modulation unresolved"]},{"year":2007,"claim":"Revealed that Zic2 transcriptional activity is regulated by DNA-PK phosphorylation at Ser200, driving exchange between DNA-PK/PARP and RNA helicase A nuclear complexes coupled to RNA Pol II.","evidence":"Co-IP, subnuclear fractionation, in vitro phosphorylation, and S200A mutagenesis with reporter assays","pmids":["17251188","18068128"],"confidence":"High","gaps":["In vivo relevance of these complexes in development not tested","Target genes regulated by this switch unknown"]},{"year":2008,"claim":"Identified EphB1 as a direct, functional Zic2 target mediating axon repulsion, while showing an EphB1-independent divergence arm also exists.","evidence":"Retinal explant electroporation with EphB1 detection, ephrinB2 avoidance assays, and mouse genetics","pmids":["18417618","18524895"],"confidence":"High","gaps":["EphB1-independent pathway effectors not defined"]},{"year":2008,"claim":"Pinpointed the developmental origin of Zic2-associated HPE to transient organizer/prechordal plate failure at gastrulation, upstream and independent of Shh.","evidence":"Mouse genetics with prechordal plate markers and Shh-pathway epistasis","pmids":["18617531"],"confidence":"High","gaps":["Upstream signal placing Zic2 in the organizer not yet defined at this point"]},{"year":2010,"claim":"Extended Zic2 control beyond axon guidance to activity-dependent axonal refinement via direct regulation of the serotonin transporter.","evidence":"Gain-of-function electroporation with pharmacological Sert blockade and refinement assays","pmids":["20676059"],"confidence":"High","gaps":["Mechanism linking Sert to refinement only partly defined"]},{"year":2011,"claim":"Positioned ZIC2 as a node intersecting Wnt and Hedgehog signaling through direct protein interactions with TCF4 and Gli proteins.","evidence":"Co-IP with domain mapping, reporter assays, Xenopus axis duplication, and PSM explants","pmids":["21908606","21661123","21211521"],"confidence":"Medium","gaps":["Context-dependence of activator vs repressor outcomes unresolved","Single-lab interaction data for Gli partners"]},{"year":2013,"claim":"Generalized the ipsilaterality program beyond the retina by showing Zic2 induces EphA4 and represses Robo3 to route dorsospinal and thalamocortical axons.","evidence":"Bidirectional in vivo genetics with axon tracing and gene expression analysis","pmids":["24360543"],"confidence":"High","gaps":["Directness of Robo3 repression not fully established"]},{"year":2014,"claim":"Identified a role for Zic2 in node ciliogenesis and left-right axis determination through upstream control of ciliogenesis regulators.","evidence":"Mouse genetics with electron microscopy and in situ analysis of Noto/Rfx3/Foxj1/Pkd1l1","pmids":["24585447"],"confidence":"Medium","gaps":["Directness of ciliogenesis gene regulation unknown","Single-lab morphological study"]},{"year":2015,"claim":"Established ZIC2 as a genome-wide enhancer-binding factor that partners with chromatin machinery (Mbd3/NuRD, NURF) to control differentiation and stem cell self-renewal.","evidence":"ChIP-seq, biochemical co-purification, and loss-of-function in ESCs and liver cancer stem cells","pmids":["25699711","26426078"],"confidence":"High","gaps":["How ZIC2 selects activating vs repressive chromatin outcomes unresolved"]},{"year":2015,"claim":"Linked Zic2 enhancer activity to neuronal migration programs, with EphB1 mediating part of the migratory phenotype.","evidence":"Conditional/hypomorphic mouse mutants with in vivo cell tracking and electroporation","pmids":["26269635"],"confidence":"Medium","gaps":["EphB1-independent migratory effectors not defined"]},{"year":2016,"claim":"Defined the molecular link between NODAL signaling and ZIC2 by showing direct SMAD2/3 interaction and joint regulation of FOXA2, explaining prechordal plate HPE.","evidence":"Reciprocal Co-IP, FOXA2 reporter assays, Xenopus assays, and HPE-variant mutagenesis","pmids":["27466203"],"confidence":"High","gaps":["Genome-wide SMAD/ZIC2 co-occupancy not mapped"]},{"year":2017,"claim":"Identified an endogenous chromatin-repressive role for ZIC2 in tethering PRC2 and maintaining H3K27me3, while also being a target of viral ubiquitination.","evidence":"Co-IP, ubiquitination assay, and ChIP-seq in KSHV-infected cells","pmids":["28835494"],"confidence":"Medium","gaps":["Whether ZIC2-PRC2 tethering operates at developmental loci unknown"]},{"year":2017,"claim":"Expanded the cancer-relevant target repertoire by showing direct ZIC2 promoter binding and activation of PAK4 feeding into Raf/MEK/ERK.","evidence":"ChIP, reporter assays, and knockdown/rescue in hepatocellular carcinoma","pmids":["28577975"],"confidence":"Medium","gaps":["Single-cancer-context study","Directness of pathway coupling partly inferred"]},{"year":2018,"claim":"Showed ZIC2 binds a low-affinity Nodal node enhancer to activate Nodal and initiate the left-determining cascade, and directly regulates the HPE gene Tgif1.","evidence":"ChIP-seq, in vitro binding/transcription assays, binding-site mutagenesis, and mouse mutant analysis","pmids":["29992973","29391420"],"confidence":"Medium","gaps":["Affinity hierarchy between ZBS and GLI sites only partly characterized in vivo"]},{"year":2018,"claim":"Connected zinc finger domain integrity to ZIC2 function by showing a schizophrenia-associated R409P mutation impairs DNA and cofactor binding and activation.","evidence":"In vitro reporter, DNA-binding, and cofactor-binding assays with the mutant","pmids":["22355535"],"confidence":"Medium","gaps":["Causal contribution to disease not established","In vivo consequences untested"]},{"year":2019,"claim":"Defined how ZIC2 is recruited to chromatin during pluripotency exit, with Zfp281 stabilizing it at enhancers/promoters and Ehmt1 acting downstream.","evidence":"CRISPR screening, genetic epistasis, and chromatin binding analysis in ESCs/EpiSCs","pmids":["31782544","28455373"],"confidence":"Medium","gaps":["Biochemical basis of Zfp281-ZIC2 stabilization not resolved"]},{"year":2020,"claim":"Broadened the ZIC2 axon-guidance program to include non-canonical Wnt5a rewiring acting with EphB1 to phosphorylate β-catenin for repulsion.","evidence":"Bidirectional in vivo genetics with transcriptomics and axon tracing","pmids":["33188033"],"confidence":"Medium","gaps":["Which Wnt receptors are direct ZIC2 targets not fully defined"]},{"year":2020,"claim":"Established ZIC2 as a context-dependent regulator of multiple cancer pathways, repressing STAT3 in breast cancer while being required for cardiac progenitor differentiation.","evidence":"ChIP-seq/RNA-seq with rescue in breast cancer, and genome-wide CRISPR screen in hPSCs","pmids":["32064600","32129551"],"confidence":"Medium","gaps":["Determinants of tumor-suppressive vs oncogenic ZIC2 behavior unresolved"]},{"year":2020,"claim":"Demonstrated combinatorial enhancer activation by SOX2 and ZIC2 at the Sox2 D1 enhancer in neural tube and neural crest.","evidence":"Chicken embryo electroporation with binding-site mutagenesis and ChIP","pmids":["31997540"],"confidence":"Medium","gaps":["Endogenous requirement vs sufficiency not fully separated"]},{"year":2021,"claim":"Showed multilevel ZIC2 enhancement of Wnt/β-catenin signaling in colon cancer by repressing Axin2 and binding β-catenin, with additional activation of Src and SNHG12 targets.","evidence":"ChIP, Co-IP, reporter, and functional assays across colon, lung, and endometrial cancer models","pmids":["34099631","34514099","34278490"],"confidence":"Medium","gaps":["Apparent opposite Wnt regulation vs TCF4 inhibition not mechanistically reconciled"]},{"year":2023,"claim":"Linked upstream epigenetic and transcriptional control of ZIC2 (hypomethylation, H3K4me3, FOXM1) to downstream RUNX2 activation and immune modulation via JUNB.","evidence":"RNA-seq/ATAC-seq/ChIP-PCR/methylation analysis in ccRCC and NPC tumor models","pmids":["37496990","37479694"],"confidence":"Medium","gaps":["Single-cancer-context mechanisms","Generalizability of upstream regulation unknown"]},{"year":2024,"claim":"Resolved how partner chromatin remodelers direct ZIC2 enhancer occupancy: ARID1A-BAF targets ZIC2 to EMT enhancers in cranial neural crest, and ZIC2/ZIC3 recruit SWI/SNF to activate primed-pluripotency enhancers.","evidence":"ChIP-seq/ATAC-seq in patient iPSC-derived CNCCs and hESCs, with bidirectional in vivo genetics and SWI/SNF degradation","pmids":["39226899","39358345"],"confidence":"High","gaps":["How ZIC2 toggles between EMT and neuronal enhancer programs not fully defined","Direct ZIC2-SWI/SNF contact surface unmapped"]},{"year":null,"claim":"The rules governing whether ZIC2 acts as an activator or repressor at a given enhancer—and how it integrates NODAL, Wnt, and Hedgehog inputs with specific chromatin remodeler partners in each developmental and cancer context—remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking partner choice to activation vs repression","Context-specific direct target sets incompletely mapped","Phosphorylation switch not connected to defined developmental loci"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,5,19,22,27,31,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,3,7,26,27,28]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[19,25,41]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,15]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[19,24,25,40,41]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,5,6,12,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[19,22,25,41]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[14,15,22,30]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[19,24,40,41]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,20,23,31,34]}],"complexes":["Mbd3/NuRD","NURF","SWI/SNF (BAF)","PRC2"],"partners":["SMAD2","SMAD3","TCF4","GLI1","GLI2","ARID1A","ZFP281","SOX2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95409","full_name":"Zinc finger protein ZIC 2","aliases":["Zinc finger protein of the cerebellum 2"],"length_aa":532,"mass_kda":55.0,"function":"Acts as a transcriptional activator or repressor. Plays important roles in the early stage of organogenesis of the CNS. Activates the transcription of the serotonin transporter SERT in uncrossed ipsilateral retinal ganglion cells (iRGCs) to refine eye-specific projections in primary visual targets. Its transcriptional activity is repressed by MDFIC. Involved in the formation of the ipsilateral retinal projection at the optic chiasm midline. Drives the expression of EPHB1 on ipsilaterally projecting growth cones. Binds to the minimal GLI-consensus sequence 5'-TGGGTGGTC-3'. Associates to the basal SERT promoter region from ventrotemporal retinal segments of retinal embryos","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O95409/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ZIC2","classification":"Not Classified","n_dependent_lines":11,"n_total_lines":1208,"dependency_fraction":0.009105960264900662},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ZIC2","total_profiled":1310},"omim":[{"mim_id":"617896","title":"ZIC FAMILY, MEMBER 5; ZIC5","url":"https://www.omim.org/entry/617896"},{"mim_id":"616015","title":"RING FINGER PROTEIN 180; RNF180","url":"https://www.omim.org/entry/616015"},{"mim_id":"609637","title":"HOLOPROSENCEPHALY 5; HPE5","url":"https://www.omim.org/entry/609637"},{"mim_id":"609481","title":"ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN; ISL2","url":"https://www.omim.org/entry/609481"},{"mim_id":"608948","title":"ZIC FAMILY, MEMBER 4; ZIC4","url":"https://www.omim.org/entry/608948"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear bodies","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":150.4}],"url":"https://www.proteinatlas.org/search/ZIC2"},"hgnc":{"alias_symbol":["HPE5"],"prev_symbol":[]},"alphafold":{"accession":"O95409","domains":[{"cath_id":"3.30.160.60","chopping":"253-330","consensus_level":"medium","plddt":66.8267,"start":253,"end":330}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95409","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95409-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95409-F1-predicted_aligned_error_v6.png","plddt_mean":50.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZIC2","jax_strain_url":"https://www.jax.org/strain/search?query=ZIC2"},"sequence":{"accession":"O95409","fasta_url":"https://rest.uniprot.org/uniprotkb/O95409.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95409/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95409"}},"corpus_meta":[{"pmid":"9771712","id":"PMC_9771712","title":"Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9771712","citation_count":384,"is_preprint":false},{"pmid":"9070329","id":"PMC_9070329","title":"The expression of the mouse Zic1, Zic2, and Zic3 gene suggests an essential role for Zic genes in body pattern formation.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9070329","citation_count":281,"is_preprint":false},{"pmid":"13678579","id":"PMC_13678579","title":"Zic2 patterns binocular vision by specifying the uncrossed retinal projection.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/13678579","citation_count":209,"is_preprint":false},{"pmid":"10677508","id":"PMC_10677508","title":"Zic2 regulates the kinetics of neurulation.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10677508","citation_count":198,"is_preprint":false},{"pmid":"11285244","id":"PMC_11285244","title":"Holoprosencephaly due to mutations in ZIC2: alanine tract expansion mutations may be caused by parental somatic recombination.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11285244","citation_count":148,"is_preprint":false},{"pmid":"26426078","id":"PMC_26426078","title":"ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26426078","citation_count":133,"is_preprint":false},{"pmid":"15221788","id":"PMC_15221788","title":"Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlations.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15221788","citation_count":120,"is_preprint":false},{"pmid":"11756505","id":"PMC_11756505","title":"Zic2 controls cerebellar development in cooperation with Zic1.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11756505","citation_count":116,"is_preprint":false},{"pmid":"14651926","id":"PMC_14651926","title":"Zic2 is required for neural crest formation and hindbrain patterning during mouse development.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14651926","citation_count":106,"is_preprint":false},{"pmid":"18417618","id":"PMC_18417618","title":"Zic2 promotes axonal divergence at the optic chiasm midline by EphB1-dependent and -independent mechanisms.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18417618","citation_count":89,"is_preprint":false},{"pmid":"25699711","id":"PMC_25699711","title":"Zic2 is an enhancer-binding factor required for embryonic stem cell specification.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25699711","citation_count":84,"is_preprint":false},{"pmid":"18617531","id":"PMC_18617531","title":"Zic2-associated holoprosencephaly is caused by a transient defect in the organizer region during gastrulation.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18617531","citation_count":77,"is_preprint":false},{"pmid":"21908606","id":"PMC_21908606","title":"Transcription factor Zic2 inhibits Wnt/β-catenin protein signaling.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21908606","citation_count":71,"is_preprint":false},{"pmid":"15590697","id":"PMC_15590697","title":"In vitro analysis of partial loss-of-function ZIC2 mutations in holoprosencephaly: alanine tract expansion modulates DNA binding and transactivation.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15590697","citation_count":70,"is_preprint":false},{"pmid":"15880380","id":"PMC_15880380","title":"Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.","date":"2005","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15880380","citation_count":64,"is_preprint":false},{"pmid":"19955556","id":"PMC_19955556","title":"Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19955556","citation_count":63,"is_preprint":false},{"pmid":"24360543","id":"PMC_24360543","title":"Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS.","date":"2013","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24360543","citation_count":63,"is_preprint":false},{"pmid":"28577975","id":"PMC_28577975","title":"Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28577975","citation_count":59,"is_preprint":false},{"pmid":"15261827","id":"PMC_15261827","title":"Overlapping and distinct expression domains of Zic2 and Zic3 during mouse gastrulation.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15261827","citation_count":59,"is_preprint":false},{"pmid":"20676059","id":"PMC_20676059","title":"Zic2 regulates the expression of Sert to modulate eye-specific refinement at the visual targets.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20676059","citation_count":58,"is_preprint":false},{"pmid":"18524895","id":"PMC_18524895","title":"Zic2 regulates retinal ganglion cell axon avoidance of ephrinB2 through inducing expression of the guidance receptor EphB1.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18524895","citation_count":58,"is_preprint":false},{"pmid":"17490632","id":"PMC_17490632","title":"Zic2 and Zic3 synergistically control neurulation and segmentation of paraxial mesoderm in mouse embryo.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17490632","citation_count":54,"is_preprint":false},{"pmid":"19177455","id":"PMC_19177455","title":"The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19177455","citation_count":53,"is_preprint":false},{"pmid":"10984499","id":"PMC_10984499","title":"ZIC2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10984499","citation_count":51,"is_preprint":false},{"pmid":"17344319","id":"PMC_17344319","title":"Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17344319","citation_count":51,"is_preprint":false},{"pmid":"11038359","id":"PMC_11038359","title":"Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11038359","citation_count":50,"is_preprint":false},{"pmid":"28946549","id":"PMC_28946549","title":"Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.","date":"2017","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/28946549","citation_count":48,"is_preprint":false},{"pmid":"30260270","id":"PMC_30260270","title":"Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30260270","citation_count":48,"is_preprint":false},{"pmid":"22310223","id":"PMC_22310223","title":"Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22310223","citation_count":47,"is_preprint":false},{"pmid":"28455373","id":"PMC_28455373","title":"ChIP-seq analysis of genomic binding regions of five major transcription factors highlights a central role for ZIC2 in the mouse epiblast stem cell gene regulatory network.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28455373","citation_count":46,"is_preprint":false},{"pmid":"23555929","id":"PMC_23555929","title":"Site specific mutation of the Zic2 locus by microinjection of TALEN mRNA in mouse CD1, C3H and C57BL/6J oocytes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23555929","citation_count":46,"is_preprint":false},{"pmid":"22733541","id":"PMC_22733541","title":"The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.","date":"2012","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22733541","citation_count":44,"is_preprint":false},{"pmid":"21661123","id":"PMC_21661123","title":"Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21661123","citation_count":44,"is_preprint":false},{"pmid":"12799086","id":"PMC_12799086","title":"Immunolocalization of Zic2 expression in the developing mouse forebrain.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12799086","citation_count":43,"is_preprint":false},{"pmid":"11699604","id":"PMC_11699604","title":"Behavioral abnormalities of Zic1 and Zic2 mutant mice: implications as models for human neurological disorders.","date":"2001","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11699604","citation_count":43,"is_preprint":false},{"pmid":"28338202","id":"PMC_28338202","title":"HOXA10 promotes nasopharyngeal carcinoma cell proliferation and invasion via inducing the expression of ZIC2.","date":"2017","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28338202","citation_count":42,"is_preprint":false},{"pmid":"11479728","id":"PMC_11479728","title":"Identification of novel mutations in SHH and ZIC2 in a South American (ECLAMC) population with holoprosencephaly.","date":"2001","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11479728","citation_count":42,"is_preprint":false},{"pmid":"26318045","id":"PMC_26318045","title":"Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26318045","citation_count":37,"is_preprint":false},{"pmid":"31649488","id":"PMC_31649488","title":"Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31649488","citation_count":34,"is_preprint":false},{"pmid":"20531442","id":"PMC_20531442","title":"The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20531442","citation_count":32,"is_preprint":false},{"pmid":"31884576","id":"PMC_31884576","title":"MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2.","date":"2019","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/31884576","citation_count":31,"is_preprint":false},{"pmid":"27466203","id":"PMC_27466203","title":"Zic2 mutation causes holoprosencephaly via disruption of NODAL signalling.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27466203","citation_count":30,"is_preprint":false},{"pmid":"33767130","id":"PMC_33767130","title":"A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33767130","citation_count":30,"is_preprint":false},{"pmid":"21211521","id":"PMC_21211521","title":"A role for Zic1 and Zic2 in Myf5 regulation and somite myogenesis.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21211521","citation_count":30,"is_preprint":false},{"pmid":"17251188","id":"PMC_17251188","title":"ZIC2-dependent transcriptional regulation is mediated by DNA-dependent protein kinase, poly(ADP-ribose) polymerase, and RNA helicase A.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17251188","citation_count":30,"is_preprint":false},{"pmid":"32064600","id":"PMC_32064600","title":"ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.","date":"2020","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32064600","citation_count":29,"is_preprint":false},{"pmid":"20553611","id":"PMC_20553611","title":"Expression of the zic1, zic2, zic3, and zic4 genes in early chick embryos.","date":"2010","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/20553611","citation_count":29,"is_preprint":false},{"pmid":"35390314","id":"PMC_35390314","title":"ZIC2 promotes colorectal cancer growth and metastasis through the TGF-β signaling pathway.","date":"2022","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/35390314","citation_count":28,"is_preprint":false},{"pmid":"26269635","id":"PMC_26269635","title":"Zic2 Controls the Migration of Specific Neuronal Populations in the Developing Forebrain.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26269635","citation_count":28,"is_preprint":false},{"pmid":"31782544","id":"PMC_31782544","title":"Zfp281 orchestrates interconversion of pluripotent states by engaging Ehmt1 and Zic2.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31782544","citation_count":27,"is_preprint":false},{"pmid":"11857562","id":"PMC_11857562","title":"Possible association of NTDs with a polyhistidine tract polymorphism in the ZIC2 gene.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11857562","citation_count":27,"is_preprint":false},{"pmid":"15053986","id":"PMC_15053986","title":"Sequence relationships and expression patterns of zebrafish zic2 and zic5 genes.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15053986","citation_count":25,"is_preprint":false},{"pmid":"30483794","id":"PMC_30483794","title":"miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30483794","citation_count":25,"is_preprint":false},{"pmid":"34514099","id":"PMC_34514099","title":"Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling.","date":"2021","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/34514099","citation_count":25,"is_preprint":false},{"pmid":"30075825","id":"PMC_30075825","title":"miR-1284 Inhibits the Growth and Invasion of Breast Cancer Cells by Targeting ZIC2.","date":"2018","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/30075825","citation_count":25,"is_preprint":false},{"pmid":"33188033","id":"PMC_33188033","title":"A Zic2-regulated switch in a noncanonical Wnt/βcatenin pathway is essential for the formation of bilateral circuits.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33188033","citation_count":24,"is_preprint":false},{"pmid":"32129551","id":"PMC_32129551","title":"Genome-wide CRISPR screen identifies ZIC2 as an essential gene that controls the cell fate of early mesodermal precursors to human heart progenitors.","date":"2020","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/32129551","citation_count":24,"is_preprint":false},{"pmid":"18755297","id":"PMC_18755297","title":"Zic2 is expressed in pluripotent cells in the blastocyst and adult brain expression overlaps with makers of neurogenesis.","date":"2008","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/18755297","citation_count":24,"is_preprint":false},{"pmid":"33388042","id":"PMC_33388042","title":"De novo ZIC2 frameshift variant associated with frontonasal dysplasia in a Limousin calf.","date":"2021","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33388042","citation_count":23,"is_preprint":false},{"pmid":"28857346","id":"PMC_28857346","title":"ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28857346","citation_count":22,"is_preprint":false},{"pmid":"32922547","id":"PMC_32922547","title":"ZIC2 promotes cancer stem cell traits via up-regulating OCT4 expression in lung adenocarcinoma cells.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32922547","citation_count":21,"is_preprint":false},{"pmid":"14679585","id":"PMC_14679585","title":"Genetic variants in ZIC1, ZIC2, and ZIC3 are not major risk factors for neural tube defects in humans.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14679585","citation_count":21,"is_preprint":false},{"pmid":"37496990","id":"PMC_37496990","title":"FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37496990","citation_count":20,"is_preprint":false},{"pmid":"24585447","id":"PMC_24585447","title":"The Zic2 gene directs the formation and function of node cilia to control cardiac situs.","date":"2014","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/24585447","citation_count":20,"is_preprint":false},{"pmid":"34232917","id":"PMC_34232917","title":"Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34232917","citation_count":20,"is_preprint":false},{"pmid":"22355535","id":"PMC_22355535","title":"Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients.","date":"2011","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/22355535","citation_count":20,"is_preprint":false},{"pmid":"21638761","id":"PMC_21638761","title":"Recurrent partial rhombencephalosynapsis and holoprosencephaly in siblings with a mutation of ZIC2.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21638761","citation_count":20,"is_preprint":false},{"pmid":"28689736","id":"PMC_28689736","title":"Zebrafish zic2 controls formation of periocular neural crest and choroid fissure morphogenesis.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28689736","citation_count":19,"is_preprint":false},{"pmid":"34099631","id":"PMC_34099631","title":"Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34099631","citation_count":19,"is_preprint":false},{"pmid":"31997540","id":"PMC_31997540","title":"Sox2 gene regulation via the D1 enhancer in embryonic neural tube and neural crest by the combined action of SOX2 and ZIC2.","date":"2020","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31997540","citation_count":19,"is_preprint":false},{"pmid":"34278490","id":"PMC_34278490","title":"ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34278490","citation_count":17,"is_preprint":false},{"pmid":"29442327","id":"PMC_29442327","title":"ZIC2 in Holoprosencephaly.","date":"2018","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29442327","citation_count":16,"is_preprint":false},{"pmid":"37479694","id":"PMC_37479694","title":"ZIC2 induces pro-tumor macrophage polarization in nasopharyngeal carcinoma by activating the JUNB/MCSF axis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37479694","citation_count":16,"is_preprint":false},{"pmid":"32555352","id":"PMC_32555352","title":"The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32555352","citation_count":14,"is_preprint":false},{"pmid":"28835494","id":"PMC_28835494","title":"ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.","date":"2017","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/28835494","citation_count":13,"is_preprint":false},{"pmid":"16157407","id":"PMC_16157407","title":"Neuronal cell type-specific promoter of the alpha CaM kinase II gene is activated by Zic2, a Zic family zinc finger protein.","date":"2005","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16157407","citation_count":13,"is_preprint":false},{"pmid":"39226899","id":"PMC_39226899","title":"ARID1A-BAF coordinates ZIC2 genomic occupancy for epithelial-to-mesenchymal transition in cranial neural crest specification.","date":"2024","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39226899","citation_count":12,"is_preprint":false},{"pmid":"39358345","id":"PMC_39358345","title":"ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39358345","citation_count":11,"is_preprint":false},{"pmid":"18068128","id":"PMC_18068128","title":"Functional role of Zic2 phosphorylation in transcriptional regulation.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18068128","citation_count":11,"is_preprint":false},{"pmid":"22105922","id":"PMC_22105922","title":"Duplication of the ZIC2 gene is not associated with holoprosencephaly.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22105922","citation_count":9,"is_preprint":false},{"pmid":"35391627","id":"PMC_35391627","title":"KLF17 promotes human naive pluripotency through repressing MAPK3 and ZIC2.","date":"2022","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35391627","citation_count":9,"is_preprint":false},{"pmid":"34904327","id":"PMC_34904327","title":"Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR-564/ZIC2 axis.","date":"2022","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34904327","citation_count":9,"is_preprint":false},{"pmid":"22859937","id":"PMC_22859937","title":"Unique alterations of an ultraconserved non-coding element in the 3'UTR of ZIC2 in holoprosencephaly.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22859937","citation_count":9,"is_preprint":false},{"pmid":"29992973","id":"PMC_29992973","title":"A Requirement for Zic2 in the Regulation of Nodal Expression Underlies the Establishment of Left-Sided Identity.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29992973","citation_count":8,"is_preprint":false},{"pmid":"24677696","id":"PMC_24677696","title":"Rare nasal cleft in a patient with holoprosencephaly due to a mutation in the ZIC2 gene.","date":"2014","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/24677696","citation_count":7,"is_preprint":false},{"pmid":"29463853","id":"PMC_29463853","title":"Spina bifida-predisposing heterozygous mutations in Planar Cell Polarity genes and Zic2 reduce bone mass in young mice.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29463853","citation_count":7,"is_preprint":false},{"pmid":"22847929","id":"PMC_22847929","title":"Comparison of mutation findings in ZIC2 between microform and classical holoprosencephaly in a Brazilian cohort.","date":"2012","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/22847929","citation_count":6,"is_preprint":false},{"pmid":"29442330","id":"PMC_29442330","title":"Roles of ZIC2 in Regulation of Pluripotent Stem Cells.","date":"2018","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29442330","citation_count":5,"is_preprint":false},{"pmid":"29391420","id":"PMC_29391420","title":"Link between the causative genes of holoprosencephaly: Zic2 directly regulates Tgif1 expression.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29391420","citation_count":5,"is_preprint":false},{"pmid":"36916392","id":"PMC_36916392","title":"Dual mechanism underlying failure of neural tube closure in the Zic2 mutant mouse.","date":"2023","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/36916392","citation_count":5,"is_preprint":false},{"pmid":"24706429","id":"PMC_24706429","title":"Holoprosencephaly: ZIC2 mutation in a case with panhypopituitarism.","date":"2014","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/24706429","citation_count":5,"is_preprint":false},{"pmid":"37774522","id":"PMC_37774522","title":"ZIC2 accelerates growth and stemness in gastric cancer through the Wnt/β-catenin pathway.","date":"2023","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/37774522","citation_count":4,"is_preprint":false},{"pmid":"35969939","id":"PMC_35969939","title":"The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA.","date":"2022","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/35969939","citation_count":4,"is_preprint":false},{"pmid":"21496007","id":"PMC_21496007","title":"Holoprosencephaly and ZIC2 microdeletions: novel clinical and epidemiological specificities delineated.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21496007","citation_count":4,"is_preprint":false},{"pmid":"33557041","id":"PMC_33557041","title":"De Novo PORCN and ZIC2 Mutations in a Highly Consanguineous Family.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33557041","citation_count":4,"is_preprint":false},{"pmid":"30855487","id":"PMC_30855487","title":"Case report: a novel mutation in ZIC2 in an infant with microcephaly, holoprosencephaly, and arachnoid cyst.","date":"2019","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30855487","citation_count":4,"is_preprint":false},{"pmid":"21479430","id":"PMC_21479430","title":"No association of the polyhistidine tract polymorphism of the ZIC2 gene with neural tube defects in a South American (ECLAMC) population.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479430","citation_count":4,"is_preprint":false},{"pmid":"38282153","id":"PMC_38282153","title":"Actin filament-associated protein 1-antisense RNA1 promotes the development and invasion of tongue squamous cell carcinoma via the AFAP1-AS1/miR-133a-5p/ZIC2 axis.","date":"2024","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38282153","citation_count":3,"is_preprint":false},{"pmid":"38594503","id":"PMC_38594503","title":"Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.","date":"2024","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/38594503","citation_count":2,"is_preprint":false},{"pmid":"32695376","id":"PMC_32695376","title":"Middle interhemispheric variant of holoprosencephaly: First prenatal report of a ZIC2 missense mutation.","date":"2020","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/32695376","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47879,"output_tokens":9641,"usd":0.144126,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19947,"output_tokens":7003,"usd":0.137405,"stage2_stop_reason":"end_turn"},"total_usd":0.281531,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Heterozygous loss-of-function mutations in ZIC2 cause holoprosencephaly (HPE); haploinsufficiency for ZIC2 is sufficient to cause brain malformations, establishing ZIC2 as a dosage-sensitive transcription factor required for forebrain development.\",\n      \"method\": \"Molecular analysis of chromosome 13q32 deletions and direct sequencing of ZIC2 in HPE patients\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple independent cohorts and laboratories, loss-of-function mechanism confirmed by patient mutations and mouse models\",\n      \"pmids\": [\"9771712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Reduced Zic2 expression (knockdown) in mice causes neurulation delay resulting in HPE and spina bifida, and delays differentiation of the dorsal neural plate (roof plate and neural crest), demonstrating that Zic2 expression level is critical for the timing of neurulation.\",\n      \"method\": \"Hypomorphic Zic2 knockdown mouse model; in situ hybridization for roof plate marker Wnt3a\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct loss-of-function genetic model with defined cellular and molecular phenotype, replicated in multiple subsequent studies\",\n      \"pmids\": [\"10677508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ZIC2 and Sp3 repress Sp1-induced transcriptional activation of the human D1A dopamine receptor gene in an AR1 activator region-dependent manner; ZIC2 was identified by yeast one-hybrid screening as a factor binding AR1.\",\n      \"method\": \"Yeast one-hybrid screening, gel shift assays (EMSA), cotransfection luciferase reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast one-hybrid plus EMSA plus functional reporter assay in the same study, single lab\",\n      \"pmids\": [\"10984499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Zic1 and Zic2 bind to specific sequences in the apolipoprotein E gene promoter (regions -185/-174, -136/-125, -65/-54) and transactivate APOE gene expression.\",\n      \"method\": \"Yeast one-hybrid screening, EMSA, mutational analysis, cotransfection luciferase reporter assays, endogenous APOE protein measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (EMSA, reporter, endogenous protein), single lab\",\n      \"pmids\": [\"11038359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Zic2 and Zic1 cooperatively control cerebellar development by regulating neuronal differentiation; compound Zic1+/-/Zic2+/kd mice show cerebellar folial abnormalities with reduced cell proliferation in the external germinal layer, reduced cyclin D1, and enhanced p27/p16 expression.\",\n      \"method\": \"Compound mutant mouse genetics, in situ hybridization for zonal markers, immunohistochemistry for cell cycle regulators\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in compound mutant mice with multiple molecular readouts\",\n      \"pmids\": [\"11756505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Zic2 is expressed in retinal ganglion cells (RGCs) with an uncrossed ipsilateral trajectory; loss- and gain-of-function analyses demonstrate that Zic2 is necessary and sufficient for RGC axon repulsion by cues at the optic chiasm midline, specifying the uncrossed retinal projection.\",\n      \"method\": \"In situ hybridization, immunofluorescence, loss-of-function (Zic2 mutant mice), gain-of-function (in vivo electroporation), axon tracing\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional loss- and gain-of-function with direct axon tracing readout, replicated across subsequent studies\",\n      \"pmids\": [\"13678579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Zic2 mutation causes a delay in neural crest production and a decrease in neural crest cell number, and is required for normal hindbrain patterning (rhombomeres 3 and 5); these defects are independent of mediolateral segmentation or dorsal neurectoderm proliferation.\",\n      \"method\": \"Loss-of-function Zic2 allele (null); in situ hybridization for neural crest and hindbrain markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with multiple molecular and cellular readouts, epistasis established\",\n      \"pmids\": [\"14651926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The C-terminal region of ZIC2 contains both activation and repression domains; the C-terminal alanine tract modulates DNA binding strength and transcriptional activity in a promoter-specific manner, and expansion of the alanine tract associated with HPE alters ZIC2 function.\",\n      \"method\": \"In vitro transcriptional activity assays, DNA binding assays with alanine-tract length mutants, analysis of HPE-associated mutations\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay with mutagenesis, single lab\",\n      \"pmids\": [\"15590697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ZIC2-dependent transcriptional regulation involves two high-molecular-weight nuclear complexes: Complex I contains DNA-PKcs, Ku70/80, and PARP; Complex II contains Ku70/80 and RNA helicase A (RHA). DNA-PK phosphorylates Zic2, driving stepwise exchange from Complex I to Complex II; phosphorylated Zic2 forms a stable complex with RHA which can interact with RNA Pol II.\",\n      \"method\": \"Co-immunoprecipitation, subnuclear fractionation, in vitro phosphorylation assay, protein complex characterization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation reconstitution plus co-IP plus subnuclear localization, multiple orthogonal methods in one study\",\n      \"pmids\": [\"17251188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Serine 200 of Zic2 is a phosphorylation site targeted by DNA-PK; S200A mutation abolishes RNA helicase A (RHA) binding and diminishes transcriptional activation capacity, establishing phosphorylation-dependent regulation of Zic2 transcriptional activity.\",\n      \"method\": \"Site-directed mutagenesis, co-immunoprecipitation, transcriptional reporter assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis plus functional assay plus binding assay, single lab but multiple methods\",\n      \"pmids\": [\"18068128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zic2 is required and sufficient to change RGC axon trajectories from crossed to uncrossed; Zic2 regulates EphB1 expression in RGCs (an EphB1-dependent pathway), and also controls axon divergence via an EphB1-independent pathway.\",\n      \"method\": \"In vivo gain- and loss-of-function in mouse (electroporation, Zic2 mutants), EphB1 protein expression analysis, axon tracing\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetics plus molecular target identification replicated by two independent studies\",\n      \"pmids\": [\"18417618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ectopic delivery of Zic2 into non-ventrotemporal retinal explants induces EphB1 mRNA and protein expression in growth cones, and the upregulated EphB1 is functional, switching RGC axon behavior from extension onto to avoidance of ephrinB2 substrates, establishing a direct link between Zic2 transcription factor activity and EphB1-mediated guidance receptor expression.\",\n      \"method\": \"Retinal explant electroporation, immunofluorescence for EphB1 protein in growth cones, ephrinB2 substrate avoidance assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function in explants with direct protein detection and functional axon guidance assay\",\n      \"pmids\": [\"18524895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zic2-associated HPE is caused by a transient defect in organizer region function at mid-gastrulation, causing arrest in prechordal plate (PCP) development; this defect precedes the onset of Shh signaling and Zic2 does not interact with Shh to produce HPE.\",\n      \"method\": \"Mouse genetics (Zic2 mutants), molecular marker analysis of prechordal plate, genetic epistasis with Shh pathway mutants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple molecular markers and negative interaction with Shh pathway established\",\n      \"pmids\": [\"18617531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Zic2 controls eye-specific axonal refinement at visual targets by directly regulating expression of the serotonin transporter (Sert); RGCs ectopically expressing Zic2 show defects in axonal refinement and respond to pharmacological blockade of Sert, whereas Zic2-negative contralateral RGCs do not.\",\n      \"method\": \"Gain-of-function electroporation, pharmacological Sert blockade, axon refinement assays, ChIP/promoter analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct gain-of-function with molecular target identification and pharmacological rescue\",\n      \"pmids\": [\"20676059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ZIC2 binds directly to the DNA-binding HMG box of TCF4 via its zinc finger domain and inhibits β-catenin·TCF4-mediated transcription without affecting TCF4 DNA binding; Zic2 RNA injection blocks β-catenin-induced axis duplication in Xenopus and inhibits Wnt target gene expression.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, Xenopus axis duplication assay, morpholino knockdown in transgenic Wnt reporter Xenopus\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein-protein interaction (Co-IP with domain mapping), functional reporter assay, and in vivo Xenopus validation\",\n      \"pmids\": [\"21908606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Zic2 physically interacts with Gli1 and retains Gli1 in the nucleus, increasing Gli-mediated transcriptional activity; deletion of the C-terminal zinc finger domain of Zic2 abrogates Gli1 interaction and nuclear retention, as well as oncogenic properties in cervical cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, immunofluorescence, luciferase reporter assay, gain- and loss-of-function\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus fractionation plus functional reporter, single lab\",\n      \"pmids\": [\"21661123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Zic2 and Zic1 act as coactivators of Gli-dependent Myf5 epaxial somite-specific enhancer activity; Zic2 co-immunoprecipitates with Gli2, indicating formation of Zic2-Gli2 complexes that promote Myf5 expression. Myf5 expression in newly forming somites is delayed in Zic2 mutant embryos.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays in cell lines, presomitic mesoderm explants, in situ hybridization in Zic2 mutant embryos\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional reporter plus in vivo genetic evidence, single lab\",\n      \"pmids\": [\"21211521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Zic2 determines axonal ipsilaterality in ascending dorsospinal tracts and rostromedial thalamocortical projections by inducing EphA4 expression to prevent midline crossing, and by downregulating Robo3 to ensure axons enter dorsal tracts.\",\n      \"method\": \"In vivo gain- and loss-of-function (electroporation, conditional KO), axon tracing, immunofluorescence, gene expression analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetics with identification of two downstream molecular targets and direct axon tracing readout\",\n      \"pmids\": [\"24360543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Zic2 controls formation and function of node cilia during gastrulation to establish cardiac situs; Zic2 mutant embryos have dysmorphic, short node cilia and depleted expression of ciliogenesis regulators Noto, Rfx3, Foxj1, and Pkd1l1 at the mid-gastrula node.\",\n      \"method\": \"Mouse genetics (Zic2 mutants), electron microscopy of node cilia, in situ hybridization for ciliogenesis transcription factors\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with direct morphological analysis plus molecular marker changes, single lab\",\n      \"pmids\": [\"24585447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Zic2 preferentially binds transcriptional enhancers genome-wide in embryonic stem cells and functions with the Mbd3/NuRD complex to regulate chromatin state and transcriptional output of differentiation-linked genes; Zic2 is required for proper ESC differentiation.\",\n      \"method\": \"ChIP-seq, genome-wide molecular studies, biochemical interaction with Mbd3/NuRD, loss-of-function in ESCs\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq plus biochemical co-purification plus functional differentiation assay in a single rigorous study\",\n      \"pmids\": [\"25699711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ZIC2 acts upstream of OCT4 in liver cancer stem cells; ZIC2 recruits the NURF chromatin remodeling complex to the OCT4 promoter to initiate OCT4 transcriptional activation, thereby maintaining CSC self-renewal.\",\n      \"method\": \"ChIP assay, promoter reporter assay, co-immunoprecipitation, knockdown/overexpression with sphere formation and xenograft readouts\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus Co-IP plus functional readout, single lab\",\n      \"pmids\": [\"26426078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Zic2 controls migration of three distinct forebrain neuron populations (Cajal-Retzius cells, an amygdaloid cell group from the caudal pallium, and cells from the prethalamic neuroepithelium to the ventral lateral geniculate nucleus); EphB1, a Zic2 transcriptional target, mediates at least part of Zic2-dependent migratory events.\",\n      \"method\": \"Zic2 conditional and hypomorphic mutant mice, in vivo cell tracking, in utero electroporation, immunofluorescence\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with direct cell tracking plus target identification, single lab\",\n      \"pmids\": [\"26269635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ZIC2 physically interacts with SMAD2 and SMAD3 (the receptor-activated NODAL signal transducers) and together SMAD3 and ZIC2 regulate FOXA2 transcription; ZIC2 therefore acts downstream of the NODAL signal during prechordal plate development, and HPE-associated ZIC2 variants are deficient in SMAD-dependent transcription.\",\n      \"method\": \"Co-immunoprecipitation (ZIC2-SMAD2/3), luciferase reporter assays (FOXA2 promoter), Xenopus developmental assays, mutagenesis of HPE-associated ZIC2 variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus mutagenesis plus functional reporter plus in vivo Xenopus validation, multiple orthogonal methods\",\n      \"pmids\": [\"27466203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Zic2 directly binds the PAK4 promoter and transcriptionally activates PAK4 expression; PAK4 then modulates cell growth via the Raf/MEK/ERK pathway downstream of Zic2 in hepatocellular carcinoma.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, knockdown/rescue experiments, pathway inhibition\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter plus functional rescue, single lab\",\n      \"pmids\": [\"28577975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ZIC2 is a substrate of the KSHV K-Rta E3 ubiquitin ligase; K-Rta directly interacts with ZIC2 and ubiquitinates it. ZIC2 localizes to immediate early and early gene cluster regions of the KSHV genome, tethers polycomb repressive complex 2 (PRC2) through physical interaction, and maintains H3K27me3 marks at the K-Rta promoter to sustain viral latency.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, ChIP-seq, PRC2 interaction assay, ZIC2 depletion experiments\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus ChIP-seq, single lab studying an endogenous ZIC2 function\",\n      \"pmids\": [\"28835494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ZIC2 in ChIP-seq of epiblast stem cells (EpiSCs) preferentially binds enhancers that regulate transcription factor genes; ZIC2 binding at enhancers in ESCs primes these regions for later OTX2/ZIC2-dependent activation in EpiSCs, representing a shift from SOX2/POU5F1 in ESCs to ZIC2/OTX2 as major acting TFs in EpiSCs.\",\n      \"method\": \"ChIP-seq with in vivo biotinylated ZIC2, OTX2, SOX2, POU5F1, POU3F1 in EpiSCs\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with multiple TFs providing mechanistic regulatory network insights, rigorous methodology\",\n      \"pmids\": [\"28455373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ZIC2 directly binds a low-affinity binding site in the Nodal enhancer HBE (normally active in node precursor cells) and is required for Nodal expression at the node; loss of Zic2 prevents activation of the NODAL-dependent left-determining cascade in the lateral plate mesoderm.\",\n      \"method\": \"ChIP-seq data analysis, in vitro transcriptional assays, mutagenesis of ZIC2 binding sites, mouse Zic2 mutant gene expression analysis, 3D organ imaging\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus in vitro transcriptional assay plus mutagenesis plus in vivo validation, single lab\",\n      \"pmids\": [\"29992973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ZIC2 directly regulates Tgif1 (another HPE-causative gene) expression; Zic2-binding sites (ZBS) on the 5' flanking region of Tgif1 were identified by ChIP and in vitro DNA binding assays, and are essential for Zic2-dependent transcriptional activation. Zic2 shows higher affinity to ZBS than GLI-binding sequences.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), in vitro DNA binding assay, luciferase reporter assay with ZBS mutations\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vitro binding assay plus reporter mutagenesis, single lab, multiple methods\",\n      \"pmids\": [\"29391420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A Zic2 missense mutation (R409P) in the zinc finger domain found in schizophrenia patients shows lowered transcription-activating capacity, impaired target DNA-binding, and impaired co-factor-binding, linking zinc finger domain integrity to Zic2 transcriptional function.\",\n      \"method\": \"Luciferase reporter assay, DNA binding assay, co-factor binding assay with mutant Zic2 protein\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay with mutagenesis and multiple functional readouts, single lab\",\n      \"pmids\": [\"22355535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zfp281 stabilizes Zic2 at enhancers and promoters in epiblast stem cells; Ehmt1 (H3K9 methyltransferase) and Zic2 act downstream of Zfp281 to drive exit from the ESC naive state and restrict reprogramming of EpiSCs to naive state.\",\n      \"method\": \"Comparative CRISPR screening in ESCs and EpiSCs, gain- and loss-of-function genetics, chromatin binding analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen plus genetic epistasis plus chromatin binding, single lab\",\n      \"pmids\": [\"31782544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Zic2 switches the Wnt5a-triggered alternative (non-canonical) Wnt pathway in ipsilateral retinal neurons by regulating expression of Wnt receptors and intracellular proteins; in combination with EphB1 receptor activation at the midline, βcatenin is phosphorylated to elicit axon repulsion.\",\n      \"method\": \"In vivo gain- and loss-of-function (electroporation, Zic2 conditional KO), transcriptomic analysis of Wnt receptor expression, axon tracing\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional genetics plus molecular target identification, single lab\",\n      \"pmids\": [\"33188033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ZIC2 directly binds the STAT3 promoter and represses STAT3 transcription; ZIC2 knockdown induces STAT3 expression and increases phosphorylated STAT3 levels, and ZIC2's tumor suppressive function in breast cancer is mediated through STAT3 regulation.\",\n      \"method\": \"ChIP-seq, RNA-seq, luciferase reporter assay, siRNA knockdown/STAT3 inhibitor rescue\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus reporter assay plus functional rescue, single lab\",\n      \"pmids\": [\"32064600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ZIC2 is identified as an essential gene for cardiac progenitor formation by genome-wide CRISPR screen; ZIC2 mutant hPSCs retain pluripotency markers but fail to differentiate into cardiomyocytes, instead switching to non-cardiac lineages, with disruption of apelin receptor-related signaling during mesoderm formation.\",\n      \"method\": \"Genome-wide CRISPR-knockout screen in hPSCs, stage-specific marker analysis (MESP1, ISL1), RNA-seq, single-cell RNA-seq\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased CRISPR screen with validation, single-cell transcriptomic mechanistic follow-up, single lab\",\n      \"pmids\": [\"32129551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOX2 and ZIC2 combinatorially activate the Sox2 D1 enhancer in embryonic neural tube and neural crest; both TFs bind the D1 enhancer sequence (confirmed by ChIP), and their co-expression activates the enhancer in both neural tube and neural crest contexts.\",\n      \"method\": \"Chicken embryo electroporation, TF binding site mutagenesis, ChIP analysis\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional mutagenesis plus in vivo electroporation, single lab\",\n      \"pmids\": [\"31997540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZIC2 directly binds the Axin2 promoter to transcriptionally repress Axin2 expression, leading to accumulation and nuclear translocation of β-catenin; ZIC2 also physically interacts with β-catenin, providing multilevel enhancement of Wnt/β-catenin signaling in colon cancer.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, co-immunoprecipitation, loss-of-function with β-catenin protein level and nuclear translocation analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus Co-IP plus reporter plus functional rescue, single lab\",\n      \"pmids\": [\"34099631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZIC2 transcriptionally activates Src expression; silencing ZIC2 inactivates Src/FAK signaling and reduces anoikis resistance of NSCLC cells, placing ZIC2 upstream of Src/FAK pathway in lung cancer.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, siRNA knockdown, in vitro anoikis assay, in vivo xenograft\",\n      \"journal\": \"Molecular therapy oncolytics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter plus functional phenotypic readout, single lab\",\n      \"pmids\": [\"34514099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZIC2 directly binds the SNHG12 lncRNA promoter and activates SNHG12 transcription; ZIC2-driven SNHG12 upregulation activates Notch signaling to promote endometrial cancer cell proliferation and migration.\",\n      \"method\": \"ChIP assay, dual luciferase reporter assay, knockdown/overexpression with functional cell assays\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — ChIP and reporter plus phenotypic readout, but mechanistic pathway connection is indirect and single lab\",\n      \"pmids\": [\"34278490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ZIC2 positively regulates RUNX2 transcription in clear cell renal cell carcinoma; increased ZIC2 drives upregulation of Runx2 and downstream oncogenic functions including downregulation of NOLC1 and activation of AKT/mTOR signaling. ZIC2 expression is regulated by promoter hypomethylation and H3K4me3, and by positive transcriptional regulation from FOXM1.\",\n      \"method\": \"RNA-seq, ATAC-seq, ChIP-PCR, MS-PCR (methylation), luciferase reporter, loss-of-function/gain-of-function\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-PCR, ATAC-seq, and methylation analysis plus luciferase reporter, multiple methods, single lab\",\n      \"pmids\": [\"37496990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ZIC2 activates JUNB promoter activity (confirmed by ChIP-seq and ChIP-qPCR) and drives MCSF secretion from NPC cells via JUNB, inducing M2 polarization of tumor-associated macrophages; blockade of JUNB or MCSF reverses ZIC2-mediated macrophage polarization.\",\n      \"method\": \"ChIP-seq, ChIP-qPCR, luciferase assay, RNA-seq, knockdown/overexpression with macrophage polarization assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus luciferase plus functional rescue in multiple assays, single lab\",\n      \"pmids\": [\"37479694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BMP signaling is overactivated in Zic2 (Kumba) mutant mouse embryos, causing failed dorsolateral hinge point formation and spina bifida; RhoA/actomyosin signaling is also overactivated, causing F-actin accumulation. BMP inhibitor (dorsomorphin) rescues DLHP formation, and myosin inhibitor (Blebbistatin) normalizes actomyosin accumulation, revealing a dual-pathway mechanism.\",\n      \"method\": \"Mouse mutant embryo culture with pharmacological inhibitors (dorsomorphin, Blebbistatin), immunofluorescence for actomyosin, neural tube morphology analysis\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological rescue in genetic model with two orthogonal inhibitors revealing dual pathway, single lab\",\n      \"pmids\": [\"36916392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ARID1A-BAF chromatin remodeler regulates ZIC2 genomic occupancy at EMT enhancers during cranial neural crest specification; in ARID1A-haploinsufficient cells, ZIC2 is excluded from EMT enhancers and relocates to neuronal enhancers. ZIC2 binding at EMT enhancers is ARID1A-dependent. In vivo, deletion of Zic2 impairs NCC delamination, while ZIC2 overexpression in chick embryos elicits ectopic neural crest delamination.\",\n      \"method\": \"CSS patient iPSC-derived CNCC differentiation, ChIP-seq (ARID1A, ZIC2), ATACseq, gain-of-function in chick (electroporation), Zic2 mouse KO NCC delamination analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq with patient iPSCs plus bidirectional in vivo genetics in two species (mouse and chick) plus mechanistic epistasis, rigorous multi-method study\",\n      \"pmids\": [\"39226899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ZIC2 and ZIC3 recruit SWI/SNF to primed-specific enhancers to activate them during human primed pluripotency; loss of ZIC2/ZIC3 prevents enhancer activation similarly to SWI/SNF degradation, and also results in perturbed Polycomb activity and aberrant differentiation toward mesendoderm.\",\n      \"method\": \"Multi-omic analysis (ATAC-seq, ChIP-seq, RNA-seq) in hESC models across peri-implantation spectrum, loss-of-function of ZIC2/ZIC3, SWI/SNF degradation experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multi-omic genome-wide approach with genetic epistasis (ZIC2/3 KO vs SWI/SNF degradation), multiple orthogonal methods\",\n      \"pmids\": [\"39358345\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZIC2 is a zinc finger transcription factor that binds enhancers and promoters to activate or repress target genes (including EphB1, EphA4, Sert, OCT4, TGIF1, Nodal, FOXA2, PAK4, STAT3, Axin2, Src, JUNB) and functions through phosphorylation-regulated protein complexes (including DNA-PK/PARP/RNA helicase A), physical interactions with SMAD2/3 (NODAL pathway), TCF4 (Wnt pathway), Gli1/Gli2 (Hedgehog pathway), and Mbd3/NuRD and SWI/SNF chromatin remodelers at enhancers; it is dosage-sensitive and required for forebrain midline patterning (via prechordal plate establishment downstream of NODAL signaling), binocular visual circuit formation (by specifying ipsilateral RGC identity through EphB1/EphA4 induction), neural crest specification and EMT, node ciliogenesis and left-right axis determination, neurulation timing, cerebellar development, and stem cell state transitions.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZIC2 is a dosage-sensitive zinc finger transcription factor that patterns the embryonic forebrain midline, neural tube, and binocular visual system, and regulates stem cell state transitions through enhancer-directed control of gene expression [#0, #5, #19]. Heterozygous loss-of-function mutations cause holoprosencephaly, and reduced Zic2 dosage delays neurulation and dorsal neural plate differentiation, producing spina bifida [#0, #1]. ZIC2's forebrain function operates downstream of NODAL signaling: it physically interacts with the receptor-activated transducers SMAD2 and SMAD3 to control FOXA2 transcription during prechordal plate development, and HPE-associated variants are deficient in SMAD-dependent transcription [#22, #12]. The zinc finger domain mediates both DNA binding and protein-protein interactions, and its integrity is essential for transcriptional activity [#7, #28]. In the visual system, ZIC2 is necessary and sufficient to specify ipsilateral retinal ganglion cell identity by directly inducing EphB1 to drive midline axon repulsion, and it further shapes circuit assembly by inducing EphA4, downregulating Robo3, controlling the serotonin transporter Sert, and rewiring non-canonical Wnt5a signaling [#5, #10, #11, #17, #13, #30]. ZIC2 intersects multiple morphogen pathways as a context-dependent activator or repressor: it binds the HMG box of TCF4 to inhibit \\u03b2-catenin\\u00b7TCF4 transcription, interacts with Gli1/Gli2 to modulate Hedgehog output, and binds a low-affinity Nodal enhancer to drive node Nodal expression for left-right axis determination [#14, #15, #16, #26]. Genome-wide, ZIC2 preferentially occupies enhancers and works with chromatin machinery\\u2014the Mbd3/NuRD complex, NURF, and SWI/SNF\\u2014to set chromatin state and prime or activate cell-state-specific enhancers governing pluripotency exit and differentiation [#19, #20, #41, #25]. Its enhancer occupancy is directed by partner factors, including stabilization by Zfp281 and ARID1A-BAF-dependent targeting to EMT enhancers during cranial neural crest specification [#29, #40]. In cancer contexts ZIC2 acts as an enhancer/promoter-binding regulator of diverse targets including OCT4, PAK4, STAT3, Axin2, Src, and RUNX2 [#20, #23, #31, #34, #35, #37].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established ZIC2 as a dosage-sensitive transcription factor required for forebrain development by linking haploinsufficiency to a human malformation syndrome.\",\n      \"evidence\": \"Deletion mapping and direct ZIC2 sequencing in holoprosencephaly patients\",\n      \"pmids\": [\"9771712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define direct transcriptional targets\", \"Mechanism of dosage sensitivity not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed that Zic2 expression level controls the timing of neurulation, explaining how reduced dosage produces both HPE and spina bifida.\",\n      \"evidence\": \"Hypomorphic Zic2 knockdown mouse with roof plate marker analysis\",\n      \"pmids\": [\"10677508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular pathway linking Zic2 to neurulation timing not identified\", \"Direct targets in the neural plate unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"First identified ZIC2 as a sequence-specific DNA-binding transcription factor capable of both repression and activation at defined promoters.\",\n      \"evidence\": \"Yeast one-hybrid, EMSA, and reporter assays on D1A dopamine receptor and APOE promoters\",\n      \"pmids\": [\"10984499\", \"11038359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro promoter assays without developmental context\", \"Endogenous relevance of these targets not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated cooperative, dosage-dependent control of cerebellar neuronal differentiation by Zic genes through cell-cycle regulators.\",\n      \"evidence\": \"Compound Zic1/Zic2 mutant mouse genetics with cell-cycle marker analysis\",\n      \"pmids\": [\"11756505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of cyclin D1/p27/p16 not distinguished\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined Zic2 as the determinant of ipsilateral retinal ganglion cell identity, providing a mechanism for binocular circuit formation.\",\n      \"evidence\": \"Bidirectional loss- and gain-of-function in mouse with axon tracing\",\n      \"pmids\": [\"13678579\", \"14651926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream guidance effectors not yet identified at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped activation/repression domains and showed the C-terminal alanine tract modulates DNA binding and links HPE mutations to altered ZIC2 function.\",\n      \"evidence\": \"In vitro transcription and DNA-binding assays with alanine-tract mutants\",\n      \"pmids\": [\"15590697\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Promoter-specific effects not tested in vivo\", \"Structural basis of alanine-tract modulation unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed that Zic2 transcriptional activity is regulated by DNA-PK phosphorylation at Ser200, driving exchange between DNA-PK/PARP and RNA helicase A nuclear complexes coupled to RNA Pol II.\",\n      \"evidence\": \"Co-IP, subnuclear fractionation, in vitro phosphorylation, and S200A mutagenesis with reporter assays\",\n      \"pmids\": [\"17251188\", \"18068128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of these complexes in development not tested\", \"Target genes regulated by this switch unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified EphB1 as a direct, functional Zic2 target mediating axon repulsion, while showing an EphB1-independent divergence arm also exists.\",\n      \"evidence\": \"Retinal explant electroporation with EphB1 detection, ephrinB2 avoidance assays, and mouse genetics\",\n      \"pmids\": [\"18417618\", \"18524895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"EphB1-independent pathway effectors not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Pinpointed the developmental origin of Zic2-associated HPE to transient organizer/prechordal plate failure at gastrulation, upstream and independent of Shh.\",\n      \"evidence\": \"Mouse genetics with prechordal plate markers and Shh-pathway epistasis\",\n      \"pmids\": [\"18617531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal placing Zic2 in the organizer not yet defined at this point\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended Zic2 control beyond axon guidance to activity-dependent axonal refinement via direct regulation of the serotonin transporter.\",\n      \"evidence\": \"Gain-of-function electroporation with pharmacological Sert blockade and refinement assays\",\n      \"pmids\": [\"20676059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking Sert to refinement only partly defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Positioned ZIC2 as a node intersecting Wnt and Hedgehog signaling through direct protein interactions with TCF4 and Gli proteins.\",\n      \"evidence\": \"Co-IP with domain mapping, reporter assays, Xenopus axis duplication, and PSM explants\",\n      \"pmids\": [\"21908606\", \"21661123\", \"21211521\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context-dependence of activator vs repressor outcomes unresolved\", \"Single-lab interaction data for Gli partners\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Generalized the ipsilaterality program beyond the retina by showing Zic2 induces EphA4 and represses Robo3 to route dorsospinal and thalamocortical axons.\",\n      \"evidence\": \"Bidirectional in vivo genetics with axon tracing and gene expression analysis\",\n      \"pmids\": [\"24360543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Directness of Robo3 repression not fully established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a role for Zic2 in node ciliogenesis and left-right axis determination through upstream control of ciliogenesis regulators.\",\n      \"evidence\": \"Mouse genetics with electron microscopy and in situ analysis of Noto/Rfx3/Foxj1/Pkd1l1\",\n      \"pmids\": [\"24585447\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directness of ciliogenesis gene regulation unknown\", \"Single-lab morphological study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established ZIC2 as a genome-wide enhancer-binding factor that partners with chromatin machinery (Mbd3/NuRD, NURF) to control differentiation and stem cell self-renewal.\",\n      \"evidence\": \"ChIP-seq, biochemical co-purification, and loss-of-function in ESCs and liver cancer stem cells\",\n      \"pmids\": [\"25699711\", \"26426078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ZIC2 selects activating vs repressive chromatin outcomes unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linked Zic2 enhancer activity to neuronal migration programs, with EphB1 mediating part of the migratory phenotype.\",\n      \"evidence\": \"Conditional/hypomorphic mouse mutants with in vivo cell tracking and electroporation\",\n      \"pmids\": [\"26269635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"EphB1-independent migratory effectors not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined the molecular link between NODAL signaling and ZIC2 by showing direct SMAD2/3 interaction and joint regulation of FOXA2, explaining prechordal plate HPE.\",\n      \"evidence\": \"Reciprocal Co-IP, FOXA2 reporter assays, Xenopus assays, and HPE-variant mutagenesis\",\n      \"pmids\": [\"27466203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide SMAD/ZIC2 co-occupancy not mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified an endogenous chromatin-repressive role for ZIC2 in tethering PRC2 and maintaining H3K27me3, while also being a target of viral ubiquitination.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, and ChIP-seq in KSHV-infected cells\",\n      \"pmids\": [\"28835494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ZIC2-PRC2 tethering operates at developmental loci unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Expanded the cancer-relevant target repertoire by showing direct ZIC2 promoter binding and activation of PAK4 feeding into Raf/MEK/ERK.\",\n      \"evidence\": \"ChIP, reporter assays, and knockdown/rescue in hepatocellular carcinoma\",\n      \"pmids\": [\"28577975\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-cancer-context study\", \"Directness of pathway coupling partly inferred\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed ZIC2 binds a low-affinity Nodal node enhancer to activate Nodal and initiate the left-determining cascade, and directly regulates the HPE gene Tgif1.\",\n      \"evidence\": \"ChIP-seq, in vitro binding/transcription assays, binding-site mutagenesis, and mouse mutant analysis\",\n      \"pmids\": [\"29992973\", \"29391420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Affinity hierarchy between ZBS and GLI sites only partly characterized in vivo\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected zinc finger domain integrity to ZIC2 function by showing a schizophrenia-associated R409P mutation impairs DNA and cofactor binding and activation.\",\n      \"evidence\": \"In vitro reporter, DNA-binding, and cofactor-binding assays with the mutant\",\n      \"pmids\": [\"22355535\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal contribution to disease not established\", \"In vivo consequences untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined how ZIC2 is recruited to chromatin during pluripotency exit, with Zfp281 stabilizing it at enhancers/promoters and Ehmt1 acting downstream.\",\n      \"evidence\": \"CRISPR screening, genetic epistasis, and chromatin binding analysis in ESCs/EpiSCs\",\n      \"pmids\": [\"31782544\", \"28455373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical basis of Zfp281-ZIC2 stabilization not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Broadened the ZIC2 axon-guidance program to include non-canonical Wnt5a rewiring acting with EphB1 to phosphorylate \\u03b2-catenin for repulsion.\",\n      \"evidence\": \"Bidirectional in vivo genetics with transcriptomics and axon tracing\",\n      \"pmids\": [\"33188033\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which Wnt receptors are direct ZIC2 targets not fully defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established ZIC2 as a context-dependent regulator of multiple cancer pathways, repressing STAT3 in breast cancer while being required for cardiac progenitor differentiation.\",\n      \"evidence\": \"ChIP-seq/RNA-seq with rescue in breast cancer, and genome-wide CRISPR screen in hPSCs\",\n      \"pmids\": [\"32064600\", \"32129551\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Determinants of tumor-suppressive vs oncogenic ZIC2 behavior unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated combinatorial enhancer activation by SOX2 and ZIC2 at the Sox2 D1 enhancer in neural tube and neural crest.\",\n      \"evidence\": \"Chicken embryo electroporation with binding-site mutagenesis and ChIP\",\n      \"pmids\": [\"31997540\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous requirement vs sufficiency not fully separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed multilevel ZIC2 enhancement of Wnt/\\u03b2-catenin signaling in colon cancer by repressing Axin2 and binding \\u03b2-catenin, with additional activation of Src and SNHG12 targets.\",\n      \"evidence\": \"ChIP, Co-IP, reporter, and functional assays across colon, lung, and endometrial cancer models\",\n      \"pmids\": [\"34099631\", \"34514099\", \"34278490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apparent opposite Wnt regulation vs TCF4 inhibition not mechanistically reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linked upstream epigenetic and transcriptional control of ZIC2 (hypomethylation, H3K4me3, FOXM1) to downstream RUNX2 activation and immune modulation via JUNB.\",\n      \"evidence\": \"RNA-seq/ATAC-seq/ChIP-PCR/methylation analysis in ccRCC and NPC tumor models\",\n      \"pmids\": [\"37496990\", \"37479694\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-cancer-context mechanisms\", \"Generalizability of upstream regulation unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved how partner chromatin remodelers direct ZIC2 enhancer occupancy: ARID1A-BAF targets ZIC2 to EMT enhancers in cranial neural crest, and ZIC2/ZIC3 recruit SWI/SNF to activate primed-pluripotency enhancers.\",\n      \"evidence\": \"ChIP-seq/ATAC-seq in patient iPSC-derived CNCCs and hESCs, with bidirectional in vivo genetics and SWI/SNF degradation\",\n      \"pmids\": [\"39226899\", \"39358345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ZIC2 toggles between EMT and neuronal enhancer programs not fully defined\", \"Direct ZIC2-SWI/SNF contact surface unmapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The rules governing whether ZIC2 acts as an activator or repressor at a given enhancer\\u2014and how it integrates NODAL, Wnt, and Hedgehog inputs with specific chromatin remodeler partners in each developmental and cancer context\\u2014remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking partner choice to activation vs repression\", \"Context-specific direct target sets incompletely mapped\", \"Phosphorylation switch not connected to defined developmental loci\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 5, 19, 22, 27, 31, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 3, 7, 26, 27, 28]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [19, 25, 41]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 15]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [19, 24, 25, 40, 41]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 5, 6, 12, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [19, 22, 25, 41]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 15, 22, 30]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [19, 24, 40, 41]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 20, 23, 31, 34]}\n    ],\n    \"complexes\": [\"Mbd3/NuRD\", \"NURF\", \"SWI/SNF (BAF)\", \"PRC2\"],\n    \"partners\": [\"SMAD2\", \"SMAD3\", \"TCF4\", \"GLI1\", \"GLI2\", \"ARID1A\", \"ZFP281\", \"SOX2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}